Researchers to evaluate effectiveness of earlier efforts to prevent, delay blinding eye disease by Jim Dryden•February 26, 2016 ROBERT BOSTON PHOTO Michael A. Kass, MD, will lead a nationwide study to determine whether efforts to prevent or delay the onset of glaucoma have been effective over the course of two decades. Researchers at Washington University
NIH scientists propose novel mechanism to explain autoimmune uveitis August 18, 2015 - NIH - The inflammatory eye disorder autoimmune uveitis occurs when a person’s immune system goes awry, attacking proteins in the eye. What spurs this response is a mystery, but now a study on mice suggests that bacteria in the gut may provide
Thursday, July 2, 2015 NIH research points to microglia as potential therapeutic target in retinitis pigmentosa Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection.
newswise, Souce: Saint Louis University Medical Center ~ September 26, 2014 ST. LOUIS – In an NIH-funded clinical trial, led at Saint Louis University by professor of ophthalmology Sophia Chung, M.D., researchers aim to bring sight back to those who have lost vision due to idiopathic intracranial hypertension (IIH). IIH is a condition, of unknown
February 11, 2013 By Jim Dryden A Washington University retina specialist is one of 10 U.S. scientists selected by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), for innovative projects to improve or restore vision. The winning proposal from Rajesh C. Rao, MD, a vitreoretinal surgery fellow in the Department of